Has the news around Vertex Pharmaceuticals effected PXS share price? from what I understand this treatment only expands their market by 750 patients (300k each). PXS could learn from the approach, get the product in the market with a smaller "tried and tested" subgroup, then grow.
As a bigger question, can PXS really survive (financially) until the completion of the trial 3, and FDA result?
It was always a gamble.
Vertex Pharmaceuticals & cash
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.2¢ |
Change
0.002(10.0%) |
Mkt cap ! $26.26M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.2¢ | 2.0¢ | $30.59K | 1.466M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 51617 | 2.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.2¢ | 667194 | 7 |
View Market Depth
| Last trade - 16.10pm 03/06/2024 (20 minute delay) ? |
|
|||||
|
Last
2.1¢ |
Change
0.002 ( 5.00 %) |
||||
| Open | High | Low | Volume | ||
| 2.0¢ | 2.1¢ | 2.0¢ | 407918 | ||
| Last updated 15.02pm 03/06/2024 ? | |||||
| SNT (ASX) Chart |